Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Thiol peroxidase involved in S. pneumoniae defenses

The Streptococcus pneumoniae bacteria defends itself from high levels of hydrogen peroxide with the help of thiol peroxidase, research shows.

22 Oct 2012

GORE Septal Occluder receives FDA approval for use in REDUCE clinical study

W. L. Gore & Associates today announced that the FDA has approved the use of the new GORE Septal Occluder for inclusion in the Gore REDUCE Clinical Study. Gore is introducing this latest technology in its Gore REDUCE Clinical Study for prevention of recurrent stroke in patent foramen ovale (PFO) patients.

22 Oct 2012

Acetylsalicylic acid slows decline in brain capacity among the elderly

A daily dose of acetylsalicylic acid equivalent to a fourth of an aspirin may slow the decline in intellectual capacity among elderly individuals with high cardiovascular risk. This is shown in a study by Sahlgrenska Academy, University of Gothenburg, Sweden.

22 Oct 2012

VEGF produced by NPCs plays a strong role in influencing microglial behavior

The brain's key "breeder" cells, it turns out, do more than that. They secrete substances that boost the numbers and strength of critical brain-based immune cells believed to play a vital role in brain health. This finding adds a new dimension to our understanding of how resident stem cells and stem cell transplants may improve brain function.

22 Oct 2012

Intensive glycemic control does not reduce mortality in neurocritical care patients

A new study in BioMed Central's open access journal Critical Care suggests that intensive glycemic control does not reduce mortality in neurocritical care patients and could, in fact, lead to more neurological damage. Complicating the picture, poor glucose control also leads to worse recovery and should be avoided.

22 Oct 2012

Talk explores improved diagnostics for cardiac threat through biomedical imaging

Each year, seemingly healthy people suffer from acute heart attacks, strokes and sudden cardiac death.

20 Oct 2012

Leaders come together to discuss latest advances in neurosciences

Stony Brook Medicine's Neurosciences Institute brings together leaders in the field of neurosciences to present the latest advances in research and clinical care for neurodegenerative disorders, neuropsychiatric disorders, and neuro-ophthalmology.

20 Oct 2012

Lean principles help improve stroke treatment at Barnes-Jewish Hospital

A process developed to increase efficiency and productivity in Japanese car factories has helped improve stroke treatment at Barnes-Jewish Hospital, report researchers at Washington University School of Medicine in St. Louis.

20 Oct 2012

Dartmouth neurobiologist investigates brain's nerve cells that establish one's location and direction

The Who asked "who are you?" but Dartmouth neurobiologist Jeffrey Taube asks "where are you?" and "where are you going?" Taube is not asking philosophical or theological questions. Rather, he is investigating nerve cells in the brain that function in establishing one's location and direction.

20 Oct 2012

NIH-funded study of weight loss in adults with type 2 diabetes finds no cardiovascular benefits

An intensive diet and exercise program resulting in weight loss does not reduce cardiovascular events such as heart attack and stroke in people with longstanding type 2 diabetes, according to a study supported by the National Institutes of Health.

20 Oct 2012

Reprogrammed vascular endothelial cells from ACs shows promise against vascular disorders

A new approach for generating large numbers of circulatory system cells, known as vascular endothelial cells (VECs), from human amniotic-fluid-derived cells (ACs) is reported in a study published by Cell Press October 18th in the journal Cell. The strategy, which shows promise in mice, opens the door to establishing a vast inventory of VECs for promoting organ regeneration and treating diverse vascular disorders.

20 Oct 2012

Research director at Kessler Foundation awarded NIH grant to study effects of chemotherapy on brain

Guang Yue, PhD, director of Human Performance and Engineering Research at Kessler Foundation, has been awarded a grant by the National Institutes of Health to study the effects of chemotherapy on brain structure, neurophysiology, and psychomotor behavior.

20 Oct 2012

FDA expands approved indication for Sapien Transcatheter Heart Valve

The U.S. Food and Drug Administration today expanded the approved indication for the Sapien Transcatheter Heart Valve (THV) to include patients with aortic valve stenosis who are eligible for surgery, but who are at high risk for serious surgical complications or death.

20 Oct 2012

Reprogrammed endothelial cells for treatment of vascular disorders

A research team at Weill Cornell Medical College has discovered a way to utilize diagnostic prenatal amniocentesis cells, reprogramming them into abundant and stable endothelial cells capable of regenerating damaged blood vessels and repairing injured organs.

19 Oct 2012

Novel insight into impact that Huntington's disease has on the brain

A study led by researchers at Boston University School of Medicine (BUSM) provides novel insight into the impact that Huntington's disease has on the brain.

19 Oct 2012

Antidepressant use may increase risk of strokes caused by bleeding in the brain

Research shows that use of popular antidepressants is linked to an increased risk of some strokes caused by bleeding in the brain, but that the risk is low, according to a multi-study analysis published in the October 17, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.

19 Oct 2012

Neuralstem initiates second cohort NSI-189 Phase Ib trial in major depressive disorder

Neuralstem, Inc. announced that it has begun dosing the second cohort of patients in its ongoing Phase Ib to test the safety of NSI-189 in the treatment of major depressive disorder (MDD).

19 Oct 2012

Daily sedation interruption does not benefit critically ill, mechanically ventilated patients

For critically ill patients receiving mechanical ventilation, daily sedation interruption did not reduce the duration of mechanical ventilation or appear to offer any benefit to patients, and may have increased both sedation and analgesic use and nurse workload, according to a study appearing in JAMA.

19 Oct 2012

Jersey Shore University Medical Center recognized as Baby-Friendly hospital

Jersey Shore University Medical Center has received an international designation as a Baby-Friendly hospital. Baby-Friendly USA, Inc. is the U.S. authority for the implementation of the Baby-Friendly Hospital Initiative, a global program sponsored by the World Health Organization and the United Nations Children's Fund.

18 Oct 2012

Global anti-tuberculosis campaign now ‘at a crossroads’

Tuberculosis care and control has improved dramatically over the last two decades, but numbers of cases and deaths are still high and multidrug resistant-TB is an under-reported and ever-increasing problem, suggest findings from the World Health Organization Global TB Report 2012.

18 Oct 2012

Stroke News and Research

Further Reading

Thiol peroxidase involved in S. pneumoniae defenses

GORE Septal Occluder receives FDA approval for use in REDUCE clinical study

Acetylsalicylic acid slows decline in brain capacity among the elderly

VEGF produced by NPCs plays a strong role in influencing microglial behavior

Intensive glycemic control does not reduce mortality in neurocritical care patients

Talk explores improved diagnostics for cardiac threat through biomedical imaging

Leaders come together to discuss latest advances in neurosciences

Lean principles help improve stroke treatment at Barnes-Jewish Hospital

Dartmouth neurobiologist investigates brain's nerve cells that establish one's location and direction

NIH-funded study of weight loss in adults with type 2 diabetes finds no cardiovascular benefits

Reprogrammed vascular endothelial cells from ACs shows promise against vascular disorders

Research director at Kessler Foundation awarded NIH grant to study effects of chemotherapy on brain

FDA expands approved indication for Sapien Transcatheter Heart Valve

Reprogrammed endothelial cells for treatment of vascular disorders

Novel insight into impact that Huntington's disease has on the brain

Antidepressant use may increase risk of strokes caused by bleeding in the brain

Neuralstem initiates second cohort NSI-189 Phase Ib trial in major depressive disorder

Daily sedation interruption does not benefit critically ill, mechanically ventilated patients

Jersey Shore University Medical Center recognized as Baby-Friendly hospital

Global anti-tuberculosis campaign now ‘at a crossroads’

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News